(ACLX) Arcellx - Performance 22.7% in 12m
ACLX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
52.50%
#8 in Peer-Group
Rel. Strength
69.19%
#2373 in Stock-Universe
Total Return 12m
22.73%
#50 in Peer-Group
Total Return 5y
299.76%
#4 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 106.53 USD |
| 52 Week Low | 50.91 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 78.40 |
| Buy/Sell Signal +-5 | 0.91 |
| Support / Resistance | Levels |
|---|---|
| Support | 65.3, 62.5, 59.3, 53.6 |
| Resistance | 87.0, 83.7, 72.5, 68.6 |
12m Total Return: ACLX (22.7%) vs XBI (-6.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
5.64% | 38.5% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ACLX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ACLX
| Total Return (including Dividends) | ACLX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.10% | 3.53% | 5.22% |
| 3 Months | 7.56% | 9.10% | 16.86% |
| 12 Months | 22.73% | -6.17% | 14.81% |
| 5 Years | 299.76% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ACLX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -26.8% | 4.4% | 81% |
| 3 Months | 57.2% | 78.8% | 96.9% |
| 12 Months | -24.4% | -85.8% | 44.9% |
| 5 Years | 92.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th57.00 | -0.42% | -2.01% |
| 3 Month | %th45.50 | -1.41% | -7.96% |
| 12 Month | %th75.50 | 30.80% | 6.90% |
| 5 Years | %th98.00 | 325.04% | 172.88% |
FAQs
Does Arcellx (ACLX) outperform the market?
Yes,
over the last 12 months ACLX made 22.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months ACLX made 7.56%, while XBI made 9.10%.
Performance Comparison ACLX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ACLX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.5% | -2.1% | -21.4% | 8% |
| US NASDAQ 100 | QQQ | 1.9% | -2.5% | -22.7% | 9% |
| German DAX 40 | DAX | 2.5% | 3.8% | -34.9% | -7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.2% | -1.1% | -24.3% | 4% |
| Hongkong Hang Seng | HSI | 2.4% | -3.2% | -39.8% | -13% |
| India NIFTY 50 | INDA | 3.6% | -0.3% | -19.7% | 23% |
| Brasil Bovespa | EWZ | -0.5% | -5.2% | -48.1% | 11% |
ACLX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.2% | -3.5% | -26.1% | -4% |
| Consumer Discretionary | XLY | 0.8% | 0.2% | -13.5% | 4% |
| Consumer Staples | XLP | 1.2% | 3.2% | -21.3% | 13% |
| Energy | XLE | 2.2% | -1.9% | -16.2% | 25% |
| Financial | XLF | 1% | -1.4% | -25.4% | -7% |
| Health Care | XLV | 2.7% | 0.8% | -13.5% | 27% |
| Industrial | XLI | 0.9% | -1.2% | -28.4% | -2% |
| Materials | XLB | -0.4% | -1.6% | -26.1% | 17% |
| Real Estate | XLRE | 1.7% | 1.8% | -19.1% | 10% |
| Technology | XLK | 1.3% | -5.8% | -24.5% | 11% |
| Utilities | XLU | 2.9% | 3.1% | -22.8% | -0% |
| Aerospace & Defense | XAR | 2.7% | -4.5% | -38.6% | -27% |
| Biotech | XBI | 1.8% | -0.4% | -7.4% | 29% |
| Homebuilder | XHB | -1.4% | -5.4% | -13.5% | 18% |
| Retail | XRT | -1.5% | -1.2% | -16.9% | 11% |
ACLX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.5% | -4.48% | -11.6% | 30% |
| Natural Gas | UNG | 6.3% | 13.2% | -13% | 29% |
| Gold | GLD | 3.6% | 3.7% | -41.3% | -18% |
| Silver | SLV | 3.2% | -3.5% | -39.3% | 2% |
| Copper | CPER | 3% | -1.9% | -40% | 9% |
ACLX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.4% | 0.4% | -16.9% | 24% |
| iShares High Yield Corp. Bond | HYG | 3.2% | 1.3% | -19.9% | 12% |